Michael Barbella, Managing Editor02.17.23
EDAP TMS SA has hired medical capital equipment finance industry veteran Ken Mobeck as chief financial officer (CFO) of EDAP Technomed Inc., the company’s U.S. subsidiary.
“I am very pleased to welcome Ken onboard our U.S.subsidiary. Ken is a great addition to Ryan Rhodes’s leadership team and will be key to supporting the ongoing expansion of our U.S. organization and driving the continued strong growth of our business in the U.S.,” EDAP TMS Chairman/CEO Marc Oczachowski stated.
“Ken is the ideal candidate to be our subsidiary’s first CFO as we begin to significantly ramp up the business with the growth of our flagship Focal One Robotic HIFU platform," added EDAP Technomed CEO Ryan Rhodes. "He brings over 25 years of financial leadership across all finance disciplines with extensive experience building strong relationships to drive operating results. His knowledge of capital equipment along with his medical device and investor relations experience at leading organizations, including Accuray, will be invaluable as we move forward.”
Mobeck most recently was vice president of Finance and Investor Relations at Accuray Incorporated, a major radiation therapy firm. During his tenure with the organization, he was responsible for driving key initiatives to improve the company’s operating performance. Before that, Mobeck was vice president of Finance at optical networking firm Lumentum, where he helped raise $900 million in debt financing to grow the business from $900 million to more than $1.6 billion in three years. Prior to Lumentum, Mobeck spent more than two decades in positions with increasing levels of responsibility at several Silicon Valley’s companies, including Silicon Graphics, Hewlett Packard, KLA, and Intel Corporation, where he was involved in high-scale growth, business transformation, and mergers and acquisitions. Notably, while employed at KLA, he helped grow revenue from $1.3 billion to $2.7 billion over seven years.
“EDAP Technomed Inc. is at a critical juncture in the organization’s growth. I’m looking forward to working with Ryan and the extended team to accelerate growth in our U.S. business and provide more patients with access to our precise Focal One robotic technology,” Mobeck said.
EDAP TMS develops, manufactures, promotes, and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One in Europe and in the United States as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of prostate cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith i-move lithotripter and lasers for treating urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL).
“I am very pleased to welcome Ken onboard our U.S.subsidiary. Ken is a great addition to Ryan Rhodes’s leadership team and will be key to supporting the ongoing expansion of our U.S. organization and driving the continued strong growth of our business in the U.S.,” EDAP TMS Chairman/CEO Marc Oczachowski stated.
“Ken is the ideal candidate to be our subsidiary’s first CFO as we begin to significantly ramp up the business with the growth of our flagship Focal One Robotic HIFU platform," added EDAP Technomed CEO Ryan Rhodes. "He brings over 25 years of financial leadership across all finance disciplines with extensive experience building strong relationships to drive operating results. His knowledge of capital equipment along with his medical device and investor relations experience at leading organizations, including Accuray, will be invaluable as we move forward.”
Mobeck most recently was vice president of Finance and Investor Relations at Accuray Incorporated, a major radiation therapy firm. During his tenure with the organization, he was responsible for driving key initiatives to improve the company’s operating performance. Before that, Mobeck was vice president of Finance at optical networking firm Lumentum, where he helped raise $900 million in debt financing to grow the business from $900 million to more than $1.6 billion in three years. Prior to Lumentum, Mobeck spent more than two decades in positions with increasing levels of responsibility at several Silicon Valley’s companies, including Silicon Graphics, Hewlett Packard, KLA, and Intel Corporation, where he was involved in high-scale growth, business transformation, and mergers and acquisitions. Notably, while employed at KLA, he helped grow revenue from $1.3 billion to $2.7 billion over seven years.
“EDAP Technomed Inc. is at a critical juncture in the organization’s growth. I’m looking forward to working with Ryan and the extended team to accelerate growth in our U.S. business and provide more patients with access to our precise Focal One robotic technology,” Mobeck said.
EDAP TMS develops, manufactures, promotes, and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One in Europe and in the United States as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of prostate cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith i-move lithotripter and lasers for treating urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL).